Iradimed (IRMD) Insider Trading & Ownership $53.62 +0.62 (+1.17%) (As of 02:42 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Iradimed (NASDAQ:IRMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage37.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$585,850.00 Get IRMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Iradimed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IRMD Insider Buying and Selling by Quarter Ad WealthPressIs the Trump/Musk duo good for shares of TSLA?If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Iradimed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2024John GlennCFOSell2,500$54.18$135,450.00 12/26/2023Roger E SusiCEOSell5,000$46.00$230,000.00 12/18/2023Roger E SusiCEOSell5,000$44.08$220,400.00 (Data available from 1/1/2013 forward) IRMD Insider Trading Activity - Frequently Asked Questions Who is on Iradimed's Insider Roster? The list of insiders at Iradimed includes Anthony Vuoto, Christopher K Scott, James B Hawkins, John Glenn, Monty K Allen, and Roger E Susi. Learn more on insiders at IRMD. What percentage of Iradimed stock is owned by insiders? 37.10% of Iradimed stock is owned by insiders. Learn more on IRMD's insider holdings. Which Iradimed insiders have been selling company stock? The following insiders have sold IRMD shares in the last 24 months: Anthony Vuoto ($121,567.13), James B Hawkins ($232,853.46), John Glenn ($135,450.00), Monty K Allen ($128,239.58), and Roger E Susi ($12,177,121.23). How much insider selling is happening at Iradimed? Insiders have sold a total of 297,121 Iradimed shares in the last 24 months for a total of $12,795,231.40 sold. Iradimed Key ExecutivesMr. Roger E. Susi (Age 71)Founder, Chairman, CEO & President Compensation: $642.57kMr. John F. Glenn (Age 62)CFO & Corporate Secretary Compensation: $541.71k1 recent tradesMr. Randy WaddellVice President of Worldwide Sales & MarketingMr. Chris WilliamsonExecutive Vice President of Continuous Improvement & Information TechnologyMr. Matt GarnerControllerMr. Steve KachelmeyerVice President of Regulatory Affairs & Quality AssuranceMr. Lynn NeuhardtVice President of Research & Development More Insider Trading Tools from MarketBeat Related Companies ENOV Insider Trading WRBY Insider Trading CNMD Insider Trading TNDM Insider Trading TMDX Insider Trading SLNO Insider Trading RXST Insider Trading MDXG Insider Trading ESTA Insider Trading BLFS Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:IRMD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredFREE Book That Could Make You a Millionaire[FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off! Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Iradimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.